Nicholas A. Saccomano
Chief Executive Officer bei OnKure, Inc.
Profil
Nicholas A.
Saccomano is currently the Chief Executive Officer & Director at OnKure, Inc. He is also a Director at Think Bioscience, Inc. Dr. Saccomano previously worked as a Director at KromaTid, Inc. He was a Senior Vice President at Pfizer Inc. from 1984 to 2008.
From 2014 to 2019, he served as the Chief Scientific Officer at Array BioPharma, Inc. Prior to that, he was the Chief Technology Officer at SomaLogic Operating Co., Inc. from 2010 to 2014.
In 2008, he briefly held the position of Chief Scientific Officer at Bend Research, Inc. Dr. Saccomano also worked as a Venture Adviser at Torrey Pines Investment, Inc. Dr. Saccomano holds a doctorate degree from The Trustees of Columbia University in The City of New York, which he obtained in 1984.
He also has an undergraduate degree from The State University of New York, which he received in 1980.
Aktive Positionen von Nicholas A. Saccomano
| Unternehmen | Position | Beginn |
|---|---|---|
OnKure, Inc.
 OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | Chief Executive Officer | - |
Think Bioscience, Inc.
 Think Bioscience, Inc. BiotechnologyHealth Technology Think Bioscience, Inc. is a company that is revolutionizing synthetic biology by utilizing living systems to create better medicines. The company is based in Boulder, CO and was founded by Jerome Fox, who has been the CEO since incorporation. The company's approach to drug discovery involves a combination of applied microbiology, enzymology, and computational science to develop small-molecule therapeutics for difficult-to-treat conditions. | Director/Board Member | 06.09.2022 |
Ehemalige bekannte Positionen von Nicholas A. Saccomano
| Unternehmen | Position | Ende |
|---|---|---|
| ARRAY TECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 01.08.2019 |
SomaLogic Operating Co., Inc.
 SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO. | Chief Tech/Sci/R&D Officer | 01.05.2014 |
Bend Research, Inc.
 Bend Research, Inc. Pharmaceuticals: MajorHealth Technology Bend Research, Inc. provides drug delivery and formulation development technologies. The company is headquartered in Bend, OR. | Chief Tech/Sci/R&D Officer | 01.12.2008 |
| PFIZER, INC. | Corporate Officer/Principal | 01.05.2008 |
KromaTid, Inc.
 KromaTid, Inc. Pharmaceuticals: MajorHealth Technology KromaTid, Inc. provides products and services for mutation detection and disease diagnosis. Its services include high resolution screening of individual genes to the entire genome, sequence, location and orientation from a single assay, cost effective discovery of inversions and translocations, rapid assay development and data delivery. The company was founded by Andrew F. Ray, Susan M. Bailey, Michael Cornforth, Edwin Goodwin, and Joel S. Bedford in 2007 and is headquartered in Longmont, CO. | Director/Board Member | - |
Ausbildung von Nicholas A. Saccomano
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| The State University of New York | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | Health Technology |
KromaTid, Inc.
KromaTid, Inc. Pharmaceuticals: MajorHealth Technology KromaTid, Inc. provides products and services for mutation detection and disease diagnosis. Its services include high resolution screening of individual genes to the entire genome, sequence, location and orientation from a single assay, cost effective discovery of inversions and translocations, rapid assay development and data delivery. The company was founded by Andrew F. Ray, Susan M. Bailey, Michael Cornforth, Edwin Goodwin, and Joel S. Bedford in 2007 and is headquartered in Longmont, CO. | Health Technology |
SomaLogic Operating Co., Inc.
SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO. | Health Technology |
Bend Research, Inc.
Bend Research, Inc. Pharmaceuticals: MajorHealth Technology Bend Research, Inc. provides drug delivery and formulation development technologies. The company is headquartered in Bend, OR. | Health Technology |
Torrey Pines Investment, Inc.
 Torrey Pines Investment, Inc. Investment ManagersFinance Torrey Pines Investment, Inc (Torrey Pines Investment) is a venture capital firm is founded in 2002 by Nikolay Savchuk.The firm is headquartered San Diego, California. | Finance |
Think Bioscience, Inc.
Think Bioscience, Inc. BiotechnologyHealth Technology Think Bioscience, Inc. is a company that is revolutionizing synthetic biology by utilizing living systems to create better medicines. The company is based in Boulder, CO and was founded by Jerome Fox, who has been the CEO since incorporation. The company's approach to drug discovery involves a combination of applied microbiology, enzymology, and computational science to develop small-molecule therapeutics for difficult-to-treat conditions. | Health Technology |
